Children with type 1 diabetes had similar long-term glycemic outcomes with two different automated insulin delivery systems, researchers reported in a paper published in Diabetes Technology & Therapeutics. In a single-center study conducted at UPMC Children’s Hospital of Pittsburgh, researchers compared data between children with type 1 diabetes using the Omnipod 5 (Insulet) and those using